IMNM – immunome, inc. (US:NASDAQ)

News

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome (NASDAQ:IMNM) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $36.00 price target on the stock.
Immunome to Present at Upcoming Investor Conferences [Yahoo! Finance]
Immunome to Present at Upcoming Investor Conferences
Immunome (NASDAQ:IMNM) was upgraded by analysts at Wall Street Zen f
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com